MindMed begins phase 3 study of MM120 for anxiety disorder
First patient dosed in landmark trial for GAD treatment MindMed has announced the dosing of the first patient in its...
Month: December 2024
German cancer centre treats first patient with Elekta Evo
New CT-guided radiotherapy system offers personalised cancer treatment Berlin’s Diagnostisch Therapeutisches Zentrum (DTZ) has become the first in the world...
Nano drug delivery system heralds safer era for drug development
A team of University of Melbourne researchers from the Caruso Nanoengineering Group has created an innovative drug delivery system with...
Revolutionizing healthcare: how a 24-hour economy can transform the pharmaceutical sector
Picture this: you’re at a local pharmacy, and despite your urgent need for medication, the shelves are filled with medicinal...
Economic Watch: China’s economic recovery gains momentum amid sustained policy support
An employee works on a production line of a pharmaceutical packaging manufacturer in Lianyungang City, east China’s Jiangsu Province, Dec....
Gender-Diverse Teens May Be Less Physically Active
Transgender and gender-diverse adolescents aged between 11 and 12 years appear to be less physically active, with lower daily step...
Exploratory Analysis Identifies Biomarkers of Response in TNBC
New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to...
When to Use Anthracyclines in Early Breast Cancer
SAN ANTONIO — Patients with early-stage, node-negative, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer and...
FDA Approves Topical Tapinarof for Atopic Dermatitis
The US Food and Drug Administration (FDA) has approved tapinarof cream, 1% for the treatment of atopic dermatitis (AD) in...
FDA Approves Cosibelimab for Cutaneous SCC
The US Food and Drug Administration (FDA) has approved the immune checkpoint inhibitor cosibelimab (Unloxcyt; Checkpoint Therapeutics, Inc.) for the...
ASTP finalizes just part of HTI-2, to the disappointment of health IT developers
This first installment of the Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing and Public Health Interoperability, version two...
Parents Lose Sleep to Kids’ Eczema
Dermatology > Atopy — Study details frequent sleep loss, sleep medication use in pediatric atopic dermatitis families by Kate Kneisel,...
What Trump’s FTC picks mean for biopharma dealmaking and PBMs – Endpoints News
What Trump’s FTC picks mean for biopharma dealmaking and PBMs Endpoints News
How Henry Ford Health is boosting health equity by bridging the telehealth divide
The prominent Michigan health system Henry Ford Health recently held a two-day digital health summit titled, "Advancing Health Equity: Bridging...
Epic Nexus connects 625 hospitals to TEFCA
Epic marks one year of connecting hospitals since joining the Trusted Exchange Framework and the Common Agreement and pledges to...
Immix Biopharma reports promising CAR-T therapy results – Investing.com
Immix Biopharma reports promising CAR-T therapy results Investing.com
Yellowstone Helped Luke Grimes Blow Up. What Now?
THERE ARE A lot of big stars and even bigger presences peppered throughout the five seasons of Yellowstone. Obviously, the...
Personalis and Tempus Expand Collaboration to Biopharma – Business Wire
Personalis and Tempus Expand Collaboration to Biopharma Business Wire
CSL receives positive opinion for garadacimab in hereditary angioedema
New treatment could revolutionise care for HAE patients Global biotechnology leader CSL has announced that the European Medicines Agency’s (EMA)...
Beckley Psytech announces positive results for ELE-101 in depression trial
Phase 2a study shows promising antidepressant effects Beckley Psytech has announced positive topline results from its phase 2a study of...
